Skip to main content

ZEVTERA

Generic: ceftobiprole medocaril sodium

Data may be stale·Apr 23, 2026
Manufacturer
Basilea
NDC
68547-578
RxCUI
2703561
Route
INTRAVENOUS
ICD-10 indication
J18.9

Affordability Check

How much will you actually pay for ZEVTERA?

In 30 seconds, see every legitimate way to afford ZEVTERA — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About ZEVTERA

What is this medication? ZEVTERA, which contains the active ingredient ceftobiprole medocaril sodium, is an injectable cephalosporin antibiotic used to treat several types of serious bacterial infections. It is approved for use in adults and, for certain conditions, pediatric patients. This medication works by disrupting the ability of bacteria to create their cell walls, which eventually causes the bacteria to die and helps the body clear the infection. It is effective against a broad range of bacteria, including some strains that have developed resistance to other common antibiotics.

The primary uses for ZEVTERA include treating Staphylococcus aureus bloodstream infections, also known as bacteremia, in adults. It is also indicated for the treatment of acute bacterial skin and skin structure infections in adults and community-acquired bacterial pneumonia in both adults and children as young as three months old. Because it is administered through an intravenous infusion, it is typically given by healthcare providers in a hospital or clinical setting to manage these severe or complex bacterial conditions.

Copay & patient assistance

Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program for more details.

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Medicare Part D coverage

How ZEVTERA appears across Medicare Part D plan formularies nationally. Source: CMS monthly Prescription Drug Plan file (2026-08-31).

Covered by plans

1%

33 of 5,499 plans

Most common tier

Tier 5

On 67% of covering formularies

Prior authorization required

33%

of covering formularies

TierFormularies on this tierShare
Tier 2 (generic)1
33%
Tier 5 (specialty)2
67%

Step therapy: 0% of formularies

Quantity limits: 0% of formularies

Coverage breadth: 3 of 65 formularies

How to read this:plans on the same formulary share tier + PA rules. Your specific plan's copay depends on (a) the tier above, (b) your plan's cost-share for that tier, (c) whether you're in the initial coverage phase or past the 2026 $2,000 out-of-pocket cap. For your exact plan, check its Summary of Benefits or log in to your Medicare.gov account. Copay cards don't apply to Medicare (federal law).

Prior authorization & coverage

PayerPAStep therapyCopay tier

—

Medicare Part D

Yes——

Related drugs

How this page is sourced

  • Drug identity verified against openFDA NDC Directory.
  • Label text (when shown) originates from NLM DailyMed.
  • Copay and assistance URLs verified periodically; if you hit a broken link, tell us.

Rare-disease navigation (specialists, trials, patient communities)

ZEVTERA treats a rare condition. For in-depth disease pages on our sister site:

UniteRare.org is our sister site for rare-disease navigation — same editorial team, same accuracy standards.